Cellectar Biosciences, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 13/11/2025 | Mar 2024Filed 13/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$6.9 | −$5.7 | −$4.4 | −$5.4 | −$6.6 | −$15 | −$0.9 | −$27 | |
| −$0.57 | −$1.33 | −$1.41 | −$3.39 | −$4.30 | −$12.13 | −$5.43 | −$0.91 | |
| 12 | 4.2 | 3.2 | 1.6 | — | — | — | 29 |
Trend